Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics

Yinghua Zhao,Yang Li,Wei Liu,Shan Xing,Dan Wang,Jing Chen,Longqin Sun,Jinsong Mu,Wanli Liu,Baocai Xing,Wei Sun,Fuchu He
DOI: https://doi.org/10.1016/j.jprot.2020.103780
IF: 3.855
2020-08-01
Journal of Proteomics
Abstract:<p>Hepatocellular carcinoma (HCC) ranks fourth in cancer mortality worldwide, and third in China. Hepatitis B virus (HBV) infection is a main risk factor for HCC in China, and the early diagnosis of HCC in high-risk population is very important. However, the commonly used diagnostic biomarker alpha-fetoprotein has limitations in clinical practice. In order to identify reliable and noninvasive HCC urinary biomarkers, a high-throughput proteomics streamline was applied in the analysis of urine samples from 74 HCC and 82 high-risk patients with chronic HBV infected liver diseases. Candidate diagnostic markers were screened by feature selection algorithm, and were combined with random forest or simple voting algorithms in the training dataset. Then the multiple feature models were validated in an independent test dataset. The selected features were further verified by Multiple Reaction Monitoring (MRM) in another independent dataset. By integrating 7 features (HPX, GOT1, APOH, GLRX, APCS, NCR3LG1 and PLG) screened in the discovery phase, random forest model achieved AUC of 0.92 and 0.87 in training and test datasets, respectively, while voting model performed better with AUC of 0.94 and 0.90, respectively. In the MRM dataset, the 7 features were targeted quantified, and voting model integrating the 7 features achieved AUC of 0.95. Our work highlights the potential of noninvasive urinary protein biomarkers in HCC diagnosis with high-risk population, which will be beneficial to HCC auxiliary diagnosis and HCC surveillance.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Significance</h3><p>A high throughput urinary proteome analysis platform was committed into the discovery of noninvasive HCC biomarkers in high-risk patients with chronic HBV infected liver diseases. The combination of 7 urinary features achieved good performance in distinguishing HCC from high-risk population. The expression of the 7 features was validated by targeted MRM, and the integration of the features also worked well in the MRM dataset. This is the first time that urinary proteomic strategy was applied in discovering HCC biomarkers from high-risk population. This result will be helpful for HCC auxiliary diagnosis and surveillance in a noninvasive way.</p>
biochemical research methods
What problem does this paper attempt to address?
This paper aims to address the issue of early diagnosis of hepatocellular carcinoma (HCC), particularly in high-risk populations with chronic hepatitis B virus (HBV) infection, by identifying non-invasive urinary protein biomarkers. The main research content and findings of the paper are as follows: ### Research Background - **HCC in China**: HCC is the fourth most deadly cancer globally and ranks third in China. Approximately 55% of HCC cases in China are attributed to HBV infection. - **Limitations of existing diagnostic methods**: The commonly used diagnostic marker alpha-fetoprotein (AFP) has certain limitations in clinical application, especially in terms of sensitivity and specificity for early diagnosis. ### Research Objective - **To identify reliable non-invasive urinary biomarkers for HCC**: To identify reliable, non-invasive urinary biomarkers for HCC, researchers employed a high-throughput proteomics approach to analyze urine samples. ### Main Findings - **Identification of 7 candidate biomarkers**: Using feature selection algorithms, 7 urinary protein features (HPX, GOT1, APOH, GLRX, APCS, NCR3LG1, and PLG) were identified from 74 HCC patients and 82 high-risk patients with chronic HBV infection. - **Model validation**: In the training dataset, the random forest model (AUC=0.92) and the voting model (AUC=0.94) performed well; in the independent test dataset, these two models achieved AUCs of 0.87 and 0.90, respectively. Further validation of these 7 features using multiple reaction monitoring (MRM) technology in another independent dataset showed that the voting model integrating the 7 features achieved an AUC of 0.95. ### Conclusion - **Application potential of non-invasive urinary protein biomarkers**: This study is the first to demonstrate the feasibility of using a urinary proteomics strategy to identify HCC biomarkers in high-risk populations. These non-invasive biomarkers have significant potential for application in the auxiliary diagnosis and monitoring of HCC.